College News - November 2012The Shape of Training Review 2012-2013This review has been set up to understand and plan for the future of postgraduate medical education and training. It is an independent review, jointly sponsored by:
Direction and themes Professor David Greenaway, Vice-Chancellor of Nottingham University, was appointed in March this year to lead the review. In the first instance he brought together an Expert Advisory Group (EAG), to help determine the content and direction for this work. This group comprises medical training, patient and employers experts as well as expertise from outside the health sector. With their help, Professor Greenaway has identified the following key themes for discussion:
Evidence for the review will be gathered from a mix of stakeholders. Their views will be gathered via a combination of written and oral submissions, research evidence, site visits, surveys, discussion groups and events. Next steps A call for ideas and evidence is now live and will continue until 8 February 2013. The Review Team has planned five seminars for those involved with medical education, which will take place in all four countries, between now and January. Site visits in locations across the UK have already begun with the first of these in Northern Ireland in October. Find out more about the review at the independent Shape of Training website at: http://www.shapeoftraining.co.uk/ New MRCP(UK) Writing Group for PACESThe Federation of Royal College of Physicians of the UK is seeking doctors to join a newly formed writing group, which will produce standardised scenarios for use in PACES station 2 (history taking ) and station 4 (communication and ethics). The group will build on the work of the Scenario Editorial Committee (SEC) in developing catalogues of high quality scenarios for use throughout the UK and internationally. Members will write and review new scenarios, and attend two one-day meetings per year. The Chair will also be required to attend SEC meetings, which are held three times per year. Available roles: Members, Trainee members, Chair Christmas Art Exhibition and Sale 2012The Royal College of Physicians of Edinburgh are once again holding their annual Charity Christmas Art Exhibition and Sale on Wednesday 5th December, 4pm - 9pm at the Royal College of Physicians of Edinburgh, 9 Queen St, Edinburgh EH2 1JQ. This year the charities we are supporting are Music in Hospitals Scotland and Gordon Leitch Memorial Fund. Transparency in Clinical TrialsThe College has recently signed up to a letter, published in The Times, regarding the work which the Royal Colleges and life sciences industry have been undertaking in relation to transparency in clinical trials. Sir, The Times has done patients and the public a great service by highlighting the campaign for transparency in clinical trials. We hope you and other newspapers will also be willing to continue to highlight the important work that the healthcare professions are doing with the life sciences industry to address this complex problem. An ethical standards group (ESHLSG.org), formed by a number of medical royal colleges and professional societies, together with relevant industry bodies, has come together in support of transparency and higher standards for the benefit of patients. The Ethical Standards in Health and Life Sciences Group (ESHLSG) has already published a set of best practice principles and facts on the transparency of clinical trials. We are currently seeking the views of healthcare professionals on medical education sponsored by the pharmaceutical industry and will shortly consult on the disclosure of financial relationships between healthcare professionals and commercial organisations. The outcomes will inform our future work to bring transparency to these relationships. Healthcare professionals, pharmaceutical companies and others within the life sciences industry are committed to ethical behaviour, and progress has already been made. It is only by working together that we can most effectively deliver further improvements in transparency. We shall continue to do this, including work on the complex issue of increasing disclosure of clinical trials data.
|
 |
 |